A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial)

Por Andreas Goebel, Jatinder Bisla, Roy Carganillo, Claire Cole, Bernhard Frank, Rima Gupta, Mairi James, Joanna Kelly, Candy McCabe, Holly Milligan, Caroline Murphy, Nick Padfield, Ceri Phillips, Helen Poole, Mark Saunders, Mick Serpell, Nick Shenker, Karim Shoukrey, Lynne Wyatt, Gareth Ambler
Publicado em 2017-11-01